Asterix Health

Asterix Health, based in the UK, specializes in providing remote General Practitioner resources to enhance primary care delivery efficiency within the healthcare system. Founded in 2024, Asterix Health operates out of London, UK, focusing on delivering remote GP services. This company aims to optimize healthcare delivery through a network of GMC-registered doctors. In May 2026, Asterix Health raised GBP 2.

1 million in pre-seed funding led by TriplePoint Capital, with additional participation from D2 Fund, Entrepreneurs First, DLB Ventures and Basis Capital. The firm has successfully completed one funding deal to date, amounting to a total of GBP 2. 1 million raised. The founder's history and previous ventures are not available at this time.

Asterix specializes in providing remote General Practitioner (GP) resources aimed at enhancing the efficiency of primary care delivery within the UK healthcare system. Their core offerings include a qualified remote workforce of GMC-registered doctors who are meticulously recruited and undergo specialized training to ensure high-quality patient care. The company co-creates tailored workflows with healthcare providers to address the unique needs of each practice, thereby improving access to care while aligning with government initiatives aimed at modernizing healthcare delivery. Asterix primarily serves NHS practices and other private healthcare providers across the UK, enabling them to deliver better patient outcomes at reduced operational costs.

The services offered are designed to facilitate increased access to high-quality healthcare, particularly in light of the growing demand for remote consultations and triage services. Asterix generates revenue through partnerships with healthcare providers, primarily structured as B2B transactions. Their business model revolves around providing remote GP services, which are billed to their clients based on usage metrics or service agreements. The transaction structure typically involves healthcare providers subscribing to Asterix's services, which may include routine consultations, triage support, and specialized services for managing abnormal lab results.

While specific pricing plans for services are proprietary, Asterix’s offerings are framed to align with the financial considerations of UK healthcare providers, facilitating a cost-effective solution for enhancing patient care. The firm's revenue model allows for scalability as healthcare providers expand their reliance on remote GP services to meet the evolving needs of their patient populations. In May 2026, Asterix Health plans to utilize the GBP 2. 1 million raised in pre-seed funding to support platform expansion and scale its remote clinical workforce.

The company is designing new products to enhance its service offerings, with a focus on improving care delivery. Asterix aims to expand its market reach within the UK and potentially explore opportunities in additional European regions by 2027, thereby increasing access to its services.